FundaMental Pharma

The company develops neuroprotective molecular spacers with the aim of preventing neurodegeneration in the brain. They utilize peptides and gene therapy methods for detecting genetic variations, and specialize in a new category of medications for addressing neurological disorders, offering a pharmacological approach for patients with untreated human neurological conditions.